A novel BE transporter is a possible candidate; it is likely expressed more frequently and strongly in the AIP and DIP cell populations than in the BIP and DIN cell populations due to the low expression frequency of SLC2A9 in current AIP and DIP cell populations, particularly within the S2 region (Fig. 3B). The gene discussed is SLC2A9; the disease is autoimmune pancreatitis.